MPWT
RVMD icon

MassMutual Private Wealth & Trust’s Revolution Medicines RVMD Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.6K Buy
185
+8
+5% +$1.17K ﹤0.01% 917
2026
Q1 		$17.2K Buy
177
+61
+53% +$6.16K ﹤0.01% 1146
2025
Q4 		$9.24K Buy
116
+30
+35% +$1.97K ﹤0.01% 1425
2025
Q3 		$4.02K Hold
86
– – ﹤0.01% 1758
2025
Q2 		$3.16K Sell
86
-2
-2% -$77 ﹤0.01% 1803
2025
Q1 		$3.11K Sell
88
-32
-27% -$1.3K ﹤0.01% 1782
2024
Q4 		$5.25K Buy
120
+53
+79% +$2.67K ﹤0.01% 1517
2024
Q3 		$3.04K Hold
67
– – ﹤0.01% 1541
2024
Q2 		$2.6K Buy
67
+6
+10% +$224 ﹤0.01% 1550
2024
Q1 		$1.97K Buy
61
+21
+53% +$622 ﹤0.01% 1550
2023
Q4 		$1.15K Buy
+40
New +$961 ﹤0.01% 1653

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

MassMutual Private Wealth & Trust's RVMD Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Revolution Medicines (RVMD) stake by 4.5% in Q2 2026, buying an estimated $1.17K and bringing the position to 185 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #917.

MassMutual Private Wealth & Trust first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • MassMutual Private Wealth & Trust held 185 shares of Revolution Medicines worth $34.6K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 8 Revolution Medicines shares in Q2 2026, an estimated $1.17K.
  • Revolution Medicines made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #917 holding.
  • MassMutual Private Wealth & Trust first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.